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Abstract
Embryonic stem (ES) cells deficient in the enzyme poly(ADP-ribose) polymerase (Parp1) develop into teratocarcinoma-like tumors
when injected subcutaneously into nude mice that contain cells with giant cell-like morphology. We show here that these cells express genes
characteristic of trophoblast giant cells and thus belong to the trophectoderm lineage. In addition, Parp1/ tumors contained other
trophoblast subtypes as revealed by expression of spongiotrophoblast-specific marker genes. The extent of giant cell differentiation was
enhanced, however, as compared with spongiotrophoblast. A similar shift toward trophoblast giant cell differentiation was observed in
cultures of Parp1-deficient ES cells and in placentae of Parp1/ embryos. Analysis of other cell lineage markers demonstrated that Parp1
acts exclusively in trophoblast to suppress differentiation. Surprisingly, trophoblast derivatives were also detected in wildtype tumors and
cultured ES cells, albeit at significantly lower frequency. These data show that wildtype ES cells contain a small population of cells with
trophectoderm potential and that absence of Parp1 renders ES cells more susceptible to adopting a trophoblast phenotype.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
During mouse embryogenesis, the trophectoderm cell
lineage separates from the inner cell mass (ICM) at the
blastocyst stage and contributes exclusively to extraembry-
onic tissues. In contrast, the ICM (from which ES cells are
derived) gives rise to the embryo proper as well as to
extraembryonic mesoderm (Hogan et al., 1986). After fer-
tilization, trophoblast giant cells are the first cells that dif-
ferentiate from the mural trophectoderm and mediate im-
plantation into the uterine wall. In contrast, polar
trophectoderm cells in contact with the ICM continue to
proliferate and give rise to the trophoblast stem (TS) cells
that mainly reside in the extraembryonic (chorionic) ecto-
derm (Cross, 2000). TS cells leaving the chorionic ectoderm
form the ectoplacental cone, a structure that contains diploid
trophoblast cells at an intermediate stage of differentiation
and which contributes mainly to formation of the spongio-
trophoblast (Cross, 2000). Cells at the margins of the ecto-
placental cone continue to differentiate and form (second-
ary) trophoblast giant cells.
ES and TS cell lineages are believed to be strictly sep-
arated and controlled by different signal transduction path-
ways (Rossant, 2001). However, cells with trophoblast giant
cell-like morphology form in teratocarcinoma-like tumors
derived from the subcutaneous injection of ES cells that are
deficient in the nuclear enzyme poly(ADP-ribose) polymer-
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Fig. 1. Expression analysis of trophoblast-specific marker genes on serial sections of 3-week- old wildtype (A–D) and Parp1/ (E–N) ES cell-derived
teratocarcinoma-like tumors. (A–D) Expression of placental lactogen I (Pl1), proliferin (Plf), proliferin-related protein (Plfr), and placental lactogen II (Pl2)
was detected in wildtype ES cell-derived tumors (arrows), but was much more pronounced in Parp1/ tumors (E–H) and was localized to cells with typical
giant cell morphology (I–L). Expression of early- (Pl1), intermediate- (Plf), and late-stage (Plfr, Pl2) giant cell markers in different subsets of giant cells
identified their progression state. The spongiotrophoblast marker Tpbp was also detected in ES cell-derived tumors in a pattern nonoverlapping with Plf (M,
N). Magnification bars in (A–D): 100 m; (E–H) 200 m; (I–L) 100 m; (M, N) 100 m.
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ase (Parp1) (Nozaki et al., 1999). The differentiation of
embryonic cell lineages occurred normally in the Parp1/
tumors. Parp1 is a highly conserved, constitutively ex-
pressed factor that is localized to chromosomes and centro-
somes (Kanai et al., 2000) and is important for maintenance
of genomic integrity (de Murcia and Me´nissier-de Murcia,
1994). Parp1- deficient mice are viable and fertile, but show
an increased sensitivity to alkylating agents and -irradia-
tion (Masutani et al., 2000; Me´nissier-de Murcia et al.,
1997). Embryonic fibroblasts derived from Parp1/ mice
contain a genomically unstable tetraploid population (Sim-
bulan-Rosenthal et al., 1999), and spontaneously immortal-
ized embryonic fibroblasts show hyperploidy (Nozaki et al.,
2001). As a consequence of its activation at sites of DNA
breakage, Parp1 also contributes to cell death induction by
depleting the cell of energy sources (Ha and Snyder, 1999).
Apart from its function in DNA damage control, Parp1 is
involved in the regulation of gene expression and cell dif-
ferentiation (Bauer et al., 1995; Ohashi et al., 1984). Parp1-
deficiency causes misregulation of genes involved in cell
cycle control, DNA replication, and chromosome process-
ing or assembly (Simbulan-Rosenthal et al., 2000).
The unexpected finding of cells with trophoblast giant
cell-like appearance that differentiated from Parp1/ ES
cells in teratocarcinoma-like tumors raised several questions
that were addressed in the present study: (1) Do these
enlarged cells express typical markers of trophoblast giant
cells? (2) Are other trophoblast subtypes present in
Parp1/ tumors and does Parp1-deficiency cause an equal
increase of different trophoblast cell types? (3) Is tropho-
blast differentiation dependent on the in vivo environment
of the tumors or does it also occur in cultured ES cells in
vitro?
To investigate these questions, we took advantage of
several marker genes that are exclusively expressed in tro-
phectoderm. Trophoblast stem cell markers that become
restricted to this lineage at the blastocyst stage are the
transcription factor genes Cdx2 (Beck et al., 1995), Esrrb
(Luo et al., 1997), and Eomes (Hancock et al., 1999). Ex-
pression of genes restricted to ectoplacental cone and spon-
giotrophoblast include Tpbp (initially named 4311) (Lesci-
sin et al., 1988) and Mash2 (Guillemot et al., 1994).
Trophoblast giant cells synthesize several members of the
prolactin hormone family. Placental lactogen I (Pl1) and II
(Pl2) are expressed in early- and late-stage giant cells,
respectively (Carney et al., 1993). Prolactin-like protein A
(Prlpa) is highly expressed in secondary trophoblast giant
cells (Muller et al., 1998). Proliferin (Plf) expression over-
laps Pl1-, Prlpa-, and Pl2-synthesis and peaks around midg-
estation (Lee et al., 1988). Proliferin-related protein (Plfr) is
a late-stage giant cell marker, but Plfr expression is also
found in spongiotrophoblast cells (Carney et al., 1993).
Using these markers, we detected expression of genes char-
acteristic of both spongiotrophoblast and trophoblast giant
cells in Parp1/ tumors. We also detected trophoblast-
specific gene expression in wildtype tumors, albeit at a
significantly lower level. A similar difference in trophoblast
contribution was observed in cultured ES cells. These re-
sults demonstrate the ability of ICM-derived ES cells to
differentiate into trophoblast and reveal a role for Parp1 in
early cell lineage definition.
Materials and methods
Embryos and tumor samples
Parp1/ and wildtype embryos derived from matings
of Parp1/ and wildtype mouse lines on a mixed ICR/
129Sv genetic background were transferred into the oviduct
of ICR wildtype and Parp1/ recipients on day 0.5 of
pseudopregnancy as described previously (Suzuki et al.,
1994). Conceptuses were collected at embryonic days (E)
8.5, 11.5, and 13.5 (counting the day of the vaginal plug as
day 0.5). Whole conceptuses (E8.5, E11.5) or placentae
(E13.5) were fixed overnight in 10% formalin and processed
for paraffin histology.
Teratocarcinoma-like tumors derived from ES cell lines
J1 (wildtype) and 210-58 (Parp1/) described in Nozaki et
al. (1999) and other sets of tumors prepared similarly were
used for histological analysis. Briefly, aliquots of 2  108
cells were injected subcutaneously into both flanks of
8-week-old female BALB/c nu/nu mice (CLEA Japan, To-
kyo). Three weeks after injection, mice were euthanized and
tumors were fixed in 10% formalin overnight and processed
for routine paraffin histology.
ES cell cultures
ES cell lines J1 and 210-58 were routinely maintained on
embryonic fibroblast feeder layers in standard ES medium
containing 10% FBS, 1 mM sodium pyruvate 5.5 106 M
Fig. 2. Number of trophoblast-derived cells per area (mm2) in ES cell
tumors. Four sections were analyzed from each of four wildtype and six
Parp1/ tumors. t test values show statistical significance for all genes
analyzed (Pl1: P 0.00025; Plf: P 0.00046; Plfr: P 0.0025; Pl2: P
0.0053; Tpbp: P  0.0114).
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-mercaptoethanol, 0.1 mM MEM nonessential amino acids
and 5  105 U/ml leukemia inhibitory factor in DMEM
(Invitrogen). For trophoblast differentiation tests, ES cells
were grown for 3–7 days on gelatin-coated dishes without
feeder cell layers in ES cell medium, ES cell medium
containing 10 ng/ml basic fibroblast growth factor (bFGF;
Sigma), standard TS cell medium (Tanaka et al., 1998), and
differentiating TS cell medium. Standard TS cell medium
contained 20% FBS, 1 mM sodium pyruvate, 5.5 106 M
-mercaptoethanol and 10 ng/ml bFGF in RPMI 1640 (In-
vitrogen), with 70% of the medium being preconditioned by
incubation on embryonic fibroblasts. Differentiating TS cell
medium consisted of 20% FBS, 1 mM sodium pyruvate, 5.5
 106 M -mercaptoethanol in RPMI 1640 only.
RNA preparation and Northern blot hybridization
Total RNA from ES cell cultures was prepared by using
Trizol Reagent (Invitrogen), and 15–20 g were electro-
phoresed in 1.2% formaldehyde agarose gels and blotted
onto GeneScreen Nylon membrane (NEN Life Science
Products). Random-primed DNA labeling was carried out
with 30 Ci of 32P-dCTP, and Northern blot hybridizations
were performed by using standard conditions (Sambrook et
al., 1989).
RNase protection assay
Total RNA (20 g) was analyzed with 32P-UTP-labeled
riboprobes using standard procedures (Yamamoto et al.,
1998). Protected fragments were resolved by acrylamide gel
electrophoresis and detected by autoradiography.
Oligonucleotide microarray analysis
Wildtype and Parp1/ ES cells were cultured in the
absence of feeder cells for 6 days with one passage in the
presence of LIF. Expression levels of wildtype and
Parp1/ ES cells were examined by GeneChip [Affime-
trix, Murine Genome U74Av2, containing a total of 12,488
genes and expressed sequence tags (ESTs)] analysis. Array
hybridizations were performed in triplicate by using cDNA
synthesized independently from wildtype and Parp1/ ES
cell mRNA. Average hybridization intensity for each array
was scaled to 1000 in order to compare multiple arrays. The
data were then analyzed by GeneSpring 4.2 (Silicon Genet-
ics).
In situ hybridization
In situ hybridizations were carried out with digoxigenin-
labeled riboprobes (Roche). For paraffin sections, standard
procedures were applied and signals were detected by using
an anti- digoxigenin–alkaline phosphatase-conjugated anti-
body (Roche). Staining was carried out overnight by using
NBT and BCIP (Roche). For cell cultures, 5  105 ES
cells/well were plated onto gelatin-coated coverslips in six-
well dishes and grown for 5 days under the conditions
described (ES, ES  bFGF, TS, diff. TS). Statistical anal-
ysis (t test) was performed for cells grown under standard
ES cell conditions. For each experiment and cell line, cells
from one to three coverslips were trypsinized and counted to
determine the total number of cells/coverslip. Cells grown
in parallel were processed for in situ hybridization. Detec-
tion was performed as above with BCIP/NBT staining for
7–9 h.
Results
Trophoblast subtypes in ES cell-derived tumors
To characterize the giant cells that formed in Parp1-
deficient teratocarcinoma-like tumors, we analyzed the ex-
pression of trophoblast giant cell-specific marker genes Pl1,
Plf, Plfr, and Pl2. Expression of all genes was detected and
was localized to cells with characteristic giant cell morphol-
ogy (Fig. 1). Pl1 and Pl2 mRNAs were confined to different
subsets of cells within large giant cell clusters, thus distin-
guishing early and late stages of giant cell differentiation
(Fig. 1E, H, I, and L). Plf-expressing cells were the most
frequently detected in Parp1/ tumors overlapping both
Pl1- and Pl2-positive cell populations consistent with ex-
pression of this marker in early- and late-stage giant cells
(Fig. 1F and J). In addition, expression of the spongiotro-
phoblast-specific gene Tpbp was consistently observed in
the tumors in a pattern that was nonoverlapping with Plf
staining (Fig. 1M and N).
Surprisingly, a very small cell population expressing
trophoblast-specific genes was also found in tumors devel-
oped from wildtype (Fig. 1A–D) ES cells. Unlike the
Parp1-deficient tumors, however, none of the wildtype tu-
mors formed hemorrhagic areas, and trophoblast giant cells
were never seen in large aggregates interspersed with blood
cells. The absolute number of cells that expressed tropho-
blast-specific genes in the wildtype tumors was extremely
low and differed significantly from the number of positive
cells in the Parp1/ tumors (Fig. 2). To determine whether
Parp1-deficiency caused an equal increase of different tro-
phoblast subtypes or whether it specifically promoted giant
cell differentiation, the ratios between trophoblast giant cell
and spongiotrophoblast cell (Tpbp-positive) numbers were
calculated. Giant cell/spongiotrophoblast ratios were on av-
erage threefold higher in Parp1/ tumors, suggesting a
relative enhancement of trophoblast giant cell differentia-
tion in the absence of Parp1.
Analysis of Parp1/ placentae
Although Parp1/ embryos are viable, the abundance
of trophoblast-derived cells and altered giant cell to spon-
giotrophoblast ratios in the Parp1/ teratocarcinoma-like
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tumors suggested a potential effect of Parp1-deficiency on
placental development. Placentae from Parp1/ and wild-
type embryos developed in wildtype females as well as
wildtype embryos developed in Parp1/ mothers were
analyzed at E8.5, 11.5, and 13.5 for morphological differ-
ences and expression patterns of Plf, Pl2, and Tpbp. At
E8.5, morphological analysis and Plf staining suggested a
slight increase in trophoblast giant cell number in some of
the mutant conceptuses (data not shown). Much more evi-
dent, however, was a difference in spongiotrophoblast
growth at E11.5 between placentae of wildtype and
Parp1/ embryos. In situ hybridization with Tpbp re-
vealed the frequent occurrence of spongiotrophoblast col-
umns or isolated spongiotrophoblast clusters in the labyrinth
region of placentae from wildtype embryos (Fig. 3). These
growth characteristics were independent of the maternal
genotype, as 17/18 (94%) wildtype conceptuses developed
in Parp1/ mothers and 11/14 (79%) wildtype concep-
tuses developed in Parp1/ females exhibited this pattern
of spongiotrophoblast growth. In contrast, in 9/13 (69%) of
the placentae from Parp1/ embryos, the spongiotropho-
blast was thin and had a flat, sharply defined border with the
underlying labyrinth (Fig. 3E and F). Only 4/13 (31%)
placentae from Parp1/ conceptuses had a few isolated
spongiotrophoblast cells in the labyrinth zone. Area mea-
surements of spongiotrophoblast (as defined by the Tpbp-
Fig. 3. Analysis of morphology and marker gene expression of E11.5 placentae from wildtype and Parp1/ embryos developed in wildtype mothers. No
consistent difference was revealed by Pl2 (A, D) expression. Tpbp-expressing spongiotrophoblast columns and isolated clusters in the labyrinth of wildtype
placentae (arrows in B, C) were absent in Parp1/ placentae (E, F), indicating a decrease of overall spongiotrophoblast size. Magnification bars in (A, B)
and (D, E): 500 m; (C, F) 200 m.
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stained region) and total placental sizes revealed that the
spongiotrophoblast fraction was significantly lower in mu-
tant (11%) than in wildtype (14.6%) placentae (P  0.006).
Trophoblast differentiation in ES cell cultures
To determine whether trophoblast differentiation from
ES cells only occurred in teratocarcinoma-like tumors, the
differentiation potential of ES cells was also investigated in
vitro. As judged by morphological criteria used for tropho-
blast stem (TS) cell cultures (Tanaka et al., 1998), such as
cell and nuclear size, perinuclear accumulation of rough
endoplasmatic reticulum and a clear appearance of the cy-
toplasm, trophoblast giant cell-like cells were observed in
both Parp1/ and wildtype ES cell lines (Fig. 4). These
cells characteristically developed at the margins of ES cell
clumps and often appeared in small clusters, reminiscent of
trophoblast giant cell differentiation in cultured TS cells. By
Northern blot analysis of cells grown for 3, 5, and 7 days
after plating, expression of Plf mRNA was detected by 7
days (Fig. 5). In accordance with the findings in the tumors,
levels of Plf mRNA expression were much higher in the
Parp1-deficient cells. Plf mRNA expression was detected
for all culture conditions tested and growth of ES cells
under conditions used for growing TS cells did not enhance
the extent of trophoblast gene expression. However, addi-
tion of fibroblast growth factor (bFGF), a factor essential for
trophoblast stem cell maintenance (Tanaka et al., 1998),
decreased the expression of Plf mRNA (data not shown). No
signals were obtained by Northern blot hybridization for
Pl1, Pl2, and Tpbp (data not shown). In RNase protection
assays, very low expression of the spongiotrophoblast gene
Mash2 and the trophoblast stem cell gene Esrrb was de-
tected (Fig. 5), but no signals were observed for Tpbp and
the stem cell marker Cdx2. In contrast to Plf, transcript
levels of Mash2 and Esrrb were not different between
wildtype and Parp1-deficient cells and did not change sig-
nificantly during the culture period. The same was true for
the transcription factor Pou5f1 (Oct4) (Fig. 5), whose ex-
pression in vivo is downregulated as the trophectoderm
lineage forms (Palmieri et al., 1994).
To prove the trophoblast identity of cells with giant
Fig. 4. Phase contrast images of ES cell cultures grown for 5 days on gelatin-coated coverslips under standard ES conditions. In wildtype ES cell cultures,
the differentiation of large cells with giant cell-like morphology is occasionally observed (A, B). Similar clusters that tend to consist of more cells are present
in Parp1/ ES cell cultures (C, D). Magnification bars in (A, C) 200 m; (B, D) 100 m.
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cell-like morphology in the ES cell cultures, cells were
subjected to in situ hybridizations with probes for the tro-
phoblast giant cell genes Pl1, Plf, Plfr, Prlpa, and Pl2 (not
shown) as well as with the spongiotrophoblast- specific
gene Tpbp (Fig. 6). Cells with typical giant cell morphology
were found to express the trophoblast giant cell genes,
although Plf-expressing cells were the most frequently ob-
served out of all giant cell-expressed genes tested (Fig. 6K).
To investigate the heterogeneity in trophoblast giant cell
numbers in the ES cell cultures, we analyzed sections of
mouse implantation sites with the same probes. Whereas Plf
mRNA was detected in both primary and secondary giant
cells (Fig. 6B), including those undergoing endovascular
invasion (Adamson et al., 2002), Pl1, Plfr, and Prlpa
mRNAs were only detected in subpopulations of Plf-posi-
tive cells. Specifically, Pl1 mRNA expression defined pri-
mary trophoblast giant cells lining the embryonic cavity
(Fig. 6A), consistent with previous results (Carney et al.,
1993), whereas Plfr and Prlpa mRNAs were confined to
secondary giant cells surrounding the ectoplacental cone
(Fig. 6C and D). Therefore, the distribution of cells express-
ing the various trophoblast giant cell markers in cultured ES
cells was consistent with the patterns in vivo. Overall, the
number of trophoblast giant cells expressing Pl1, Plf, Plfr,
and Prlpa mRNAs were all significantly higher in the
Parp1-deficient cultures (Fig. 6K). The average frequency
of Plf-positive cells was 5  105 in 5-day wildtype cul-
tures and 8.4 105 in the Parp1/ line. In addition to the
apparent increase in trophoblast giant cell numbers, the ratio
of Plf/Tpbp-expressing cells was significantly higher in the
Parp1 mutant cells (13.3 in Parp1/ vs 9.8 in wildtype),
indicating a more pronounced trophoblast giant cell differ-
entiation consistent with the observations in the tumors.
Cell lineage-specific differentiation in Parp1-deficient ES
cells
The results of the tumor and ES cell analysis clearly
showed that trophoblast differentiation is promoted in the
absence of Parp1. We then sought to determine whether this
differentiation- promoting effect is trophoblast-specific or
whether it affects cell differentiation in general. To address
this question, a high-density oligonucleotide microarray
analysis was carried out with wildtype and Parp1/ ES
cell lines. A total of 128 genes/ESTs exhibited a threefold
difference of expression levels (P  0.05) between the 2
cell lines. Inspection of the lineage-specific genes on the
microarray (Table 1) revealed that Parp1/ ES cells ex-
hibited significant upregulation (P  0.05) of Plf, Prlpa,
and Tcfap2 (encoding transcription factor AP-2). Detection
of Plf and Prlpa upregulation was consistent with the results
obtained by Northern blot and in situ hybridization analysis.
Although the transcription factor AP-2 is not exclusively
expressed in trophoblast, it is essential for trophoblast pro-
liferation (Werling and Schorle, 2002) and might therefore
contribute to the increase in trophoblast cells in Parp1-
deficient ES cells. In contrast, cell lineage-restricted mark-
ers for neuroectoderm- (Pax6, Neurog3), mesoderm- (car-
diac actin/Actc1, Myod1, Nkx2–5, T/brachyury), or
endoderm- (Afp, Foxa2/Hnf3b, Kdr/Flk1, Tie1) specific
genes were not different between the two cell lines.
The results obtained by oligonucleotide microarray anal-
ysis were confirmed independently by Northern blot analy-
sis of wildtype and Parp1/ ES cells. The genes tested
included the endoderm markers Afp and Foxa2, skeletal
muscle differentiation marker Myod1, cardiac marker
Nkx2–5, and endothelial marker Kdr. None of these genes
Table 1
Relative expression levels as determined by GeneChip analysis of cell lineage markers in wildtype (/) and Parp1-deficient (/) ES cell lines
Gene Accession No. / / P
Trophoblast markers
Pl1 M35662 0.392 1.239 0.05
Pl2 M85067 0.272 1.315 0.05
Plf K02245 0.071 4.74 0.05
Plfr K03237 1.573 1.064 0.05
Prlpa AF011383 0.3 4.217 0.05
Tcfap2 U17291 0 2.56 0.05
Ectoderm markers
Neurog3 Y09167 0.259 1.489 0.05
Pax6 X63963 0 0 0.05
Mesoderm markers
Actc1 M15501 1.055 1.005 0.05
Myod1 M18779 0.805 0.603 0.05
Nkx2–5 AF091351 0 0 0.05
T/brachyury X51683 0.255 0 0.05
Endoderm markers
Afp V00743 0.559 0.834 0.05
Foxa2/Hnf3b L10409 0.254 1.823 0.05
Kdr/Flk1 X70842 1.9 1.601 0.05
Tie1 X80764 0.446 0.752 0.05
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exhibited elevated expression levels in Parp1/ as com-
pared with wildtype ES cells. Specifically, weak signals
were detected for Foxa2 and Kdr but were not different
between the two cell lines, whereas the other marker genes
did not show any detectable expression in the cultured cells
(data not shown). We concluded, therefore, that Parp1 is
acting on cell differentiation in the trophoblast lineage ex-
clusively.
Discussion
Parp1-deficiency was previously described to result in
the massive accumulation of cells with giant cell morphol-
ogy in ES cell-derived teratocarcinoma-like tumors devel-
oped in nude mice (Nozaki et al., 1999). We show here that
these enlarged cells express definitive markers characteristic
of trophoblast giant cells in normal embryonic development
and thus must have differentiated from a trophectoderm
precursor. This differentiation event is not dependent on the
in vivo environment provided by subcutaneous injection of
ES cells, because trophoblast giant cells were also detected
in Parp1/ ES cell cultures, albeit at a frequency of only
0.01%. The expression of Tpbp, Mash2, and Esrrb provides
evidence for the presence of other trophoblast subtypes in
both Parp1/ tumors and ES cells. Remarkably, a few
trophoblast derivatives were also detected in wildtype tu-
mors and ES cells. Whereas the difference in spongiotro-
phoblast marker-positive cells was not significantly differ-
ent between wildtype and Parp1-deficient ES cells in vitro,
giant cell numbers were significantly increased in the ab-
sence of Parp1, both in cultured ES cells and in derived
tumors. These data suggest that Parp1 regulates trophoblast
differentiation at two stages: first, the segregation of ES
cells from the trophoblast cell lineage and, second, terminal
differentiation of trophoblast giant cells (Fig. 7).
The derivation of trophoblast cells from ES cells was
initially a surprise. ES cells are established from the ICM, a
cell lineage that is clearly separated from the trophectoderm
at the blastocyst stage. In accordance with this derivation,
ES cells are capable to fully support fetal development
(Nagy et al., 1990; Nagy and Rossant, 1993). It has been
noted, however, that trophoblast giant cells are commonly
observed in early-passage ES cell lines (Brook and Gardner,
1997; Wiley, 1978). When ES cells are injected into blas-
tocysts, they mainly contribute to epiblast derivatives. How-
ever, a tiny proportion of clearly ES cell-derived giant cells
has also been described (Beddington and Robertson, 1989).
Our in situ hybridizations on wildtype (J1) ES cells prove
that this well-established cell line indeed harbors cells with
some trophectoderm potential. According to their early dif-
ferentiation during development, ES and TS cell lineages
are believed to be strictly separated and controlled by dif-
ferent signal transduction pathways and transcriptional reg-
ulators (Rossant, 2001). To date, manipulation of only one
gene, the POU domain transcription factor Oct4 (Pou5f1),
has been shown to initiate a global ES-to-TS cell switch
(Nichols et al., 1998; Niwa et al., 2000). Parp1, by contrast,
has an effect only on a very small cell population, based on
the fact that only up to 0.01% of cells in culture expressed
trophoblast markers. The frequency of trophoblast giant cell
precursors in the initial population is likely to be somewhat
higher than this number, since trophoblast giant cells are
postmitotic and thus are easily overgrown by the highly
proliferative ES cells. Nonetheless, given the relatively
modest number of trophoblast cells in the tumors and ES
cell cultures, it is unlikely that Oct4 and Parp1 act in the
same pathway to control ES cell fate.
A much more attractive explanation for the role of Parp1
in contributing to ES cell identity is provided by its cell
death-inducing function executed in dependence of apopto-
sis- inducing factor (AIF) (Yu et al., 2002). It has been
proposed that a small proportion of ICM cells—and there-
fore also ES cells—is endowed with a “pretrophectodermal”
potential and is eliminated during early development
(Parchment, 1993). An AIF-mediated role of Parp1 in this
Fig. 5. Trophoblast marker gene expression in cultured ES cells. (Top
panel) Northern blot analysis of wildtype and Parp1/ ES cells grown for
3, 5, and 7 days under standard ES conditions for Plf and Pou5f1. (Bottom
panel) RNase protection assay with the same samples for the spongiotro-
phoblast marker Mash2, stem cell marker Esrrb and Gapd.
Fig. 6. Expression of trophoblast marker genes in vivo and in ES cell cultures. (A–D) Trophoblast giant cell marker gene expression in E7.5 mouse
conceptuses showing labeling of all giant cells (Plf, in B) or of different subpopulations (Pl1, in A; Plfr, in C; Prlpa, in D). (E–J) In situ hybridization analysis
of trophoblast gene expression in wildtype (E, G, I) and Parp1/ (F, H, J) ES cells grown for 5 days under standard ES conditions. (K) Frequency of
trophoblast-derived cell subtypes in ES cell cultures. Trophoblast marker-expressing cells were more frequently observed in Parp1/, cells, with statistically
significant differences for all giant cell-specific genes (t test values: Pl1: P  0.0113; Plf: P  0.0468; Plfr: P  0.0396; Prlpa: P  0.0034; Tpbp: P 
0.3250). Magnification bars in (A–D): 250 m; (E–J) 100 m.
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elimination process is feasible as it was shown that pro-
grammed cell death occurring in early embryogenesis is
induced by this factor (Joza et al., 2001). Conceivably, these
pretrophectodermal cells survive to a greater extent in the
absence of Parp1 and represent the precursors of tropho-
blast giant cells and spongiotrophoblast cells that accumu-
late in Parp1/ ES cell cultures and their derived tumors.
This explanation is also supported by the fact that, unlike
Oct4 downregulation, Parp1-deficiency does not trigger a
general switch from ES to TS cell fate, and the majority of
Parp1/ cells retain ES cell character.
In addition to the overall increase in trophoblast cell
formation, Parp1-deficiency specifically resulted in the dif-
ferentiation of giant cells both in vitro and in vivo. The only
consistent phenotype observed in Parp1/ placentae was a
decrease in spongiotrophoblast volume that has no overt
effect on further embryonic growth, and Parp1 mutant em-
bryos are viable and are born at expected Mendelian ratios
(Masutani et al., 1999). The reduction in spongiotrophoblast
size likely reflects a skewing between spongiotrophoblast
and trophoblast giant cell populations as observed in
Parp1/ ES cells both in culture and in tumors, as the
increase in trophoblast giant cells takes place on the expense
of the spongiotrophoblast population. During embryogene-
sis, both spongiotrophoblast and (secondary) giant cells
arise from a common precursor located in the ectoplacental
cone. Whereas cells within the ectoplacental cone are at an
intermediate stage of differentiation, cells at its margins
continue to differentiate to form giant cells.
Trophoblast giant cells form by repeated rounds of DNA
replication in the absence of intervening mitoses (endoredu-
plication). Loss of Parp1 has been reported to induce en-
doreduplication and hyperploidy in embryonic fibroblasts
(Nozaki et al., 2001; Simbulan- Rosenthal et al., 1999). The
localization of Parp1 to centrosomes (Kanai et al., 2000)
might be important for this mitosis-regulating function. Al-
though differentiation-promoting effects have been reported
in various cell lines upon Parp1 inhibition (Bauer et al.,
1995; Ohashi et al., 1984), Parp1/ ES cells show no
enhanced differentiation of nontrophoblast cell types during
tumor formation (Nozaki et al., 1999) and in vitro culture.
This finding was supported by the analysis of expression
profiles and Northern blot hybridizations by using various
cell lineage markers, demonstrating that the only lineage-
specific genes consistently upregulated in the absence of
Parp1 are markers of trophoblast giant cells. These data
suggest an inhibitory role of Parp1 in cell differentiation
that is confined, at least primarily, to the trophoblast lineage.
In conclusion, we have provided evidence for a novel
role of Parp1 in suppression of a trophoblast phenotype in
ES cells and ES cell-derived tumors. Lack of Parp1 results
in a more pronounced differentiation of trophoblast sub-
types, particularly of giant cells, that exhibit the features of
cell type-specific gene expression that are characteristic of
those developed in vivo.
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